บทความที่มีข้อกำหนดการเข้าถึงสาธารณะ - Douglas Eastonดูข้อมูลเพิ่มเติม
ไม่มีให้ใช้งานในทุกที่: 21
ตรวจทาน
The genetic epidemiology of prostate cancer and its clinical implications
R Eeles, C Goh, E Castro, E Bancroft, M Guy, AAA Olama, D Easton, ...
Nature reviews Urology 11 (1), 18-31, 2014
ข้อกำหนด: US National Institutes of Health, Cancer Research UK, Prostate Cancer UK
ตรวจทาน
Risk factors for the incidence of breast cancer: do they affect survival from the disease?
GC Barnett, M Shah, K Redman, DF Easton, BAJ Ponder, PDP Pharoah
Journal of Clinical Oncology 26 (20), 3310-3316, 2008
ข้อกำหนด: Cancer Research UK
ตรวจทาน
Reproductive and Hormonal Factors, and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Results from the International BRCA1/2 Carrier Cohort …
AC Antoniou, M Rookus, N Andrieu, R Brohet, J Chang-Claude, S Peock, ...
Cancer Epidemiology Biomarkers & Prevention 18 (2), 601-610, 2009
ข้อกำหนด: Cancer Research UK
ตรวจทาน
A combined analysis of genome-wide association studies in breast cancer
J Li, K Humphreys, T Heikkinen, K Aittomäki, C Blomqvist, PDP Pharoah, ...
Breast cancer research and treatment 126, 717-727, 2011
ข้อกำหนด: US National Institutes of Health, Swedish Research Council, Cancer Research UK
ตรวจทาน
Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variants
S Jervis, H Song, A Lee, E Dicks, J Tyrer, P Harrington, DF Easton, ...
Journal of medical genetics 51 (2), 108-113, 2014
ข้อกำหนด: Cancer Research UK
ตรวจทาน
Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis
SM Collin, C Metcalfe, L Zuccolo, SJ Lewis, L Chen, A Cox, M Davis, ...
Cancer epidemiology, biomarkers & prevention 18 (9), 2528-2539, 2009
ข้อกำหนด: Cancer Research UK
ตรวจทาน
Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations
RM Brohet, ME Velthuizen, FBL Hogervorst, HEJ Meijers-Heijboer, ...
Journal of medical genetics 51 (2), 98-107, 2014
ข้อกำหนด: Cancer Research UK, Dutch Cancer Society
ตรวจทาน
Common variants in mismatch repair genes and risk of colorectal cancer
T Koessler, MZ Oestergaard, H Song, J Tyrer, B Perkins, AM Dunning, ...
Gut 57 (8), 1097-1101, 2008
ข้อกำหนด: Cancer Research UK
ตรวจทาน
Evaluating the power to discriminate between highly correlated SNPs in genetic association studies
MS Udler, J Tyrer, DF Easton
Genetic epidemiology 34 (5), 463-468, 2010
ข้อกำหนด: Cancer Research UK
ตรวจทาน
The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study
B Frank, SH Rigas, JL Bermejo, M Wiestler, K Wagner, K Hemminki, ...
Breast cancer research and treatment 111, 139-144, 2008
ข้อกำหนด: German Research Foundation, Cancer Research UK
ตรวจทาน
Educational attainment and mean leukocyte telomere length in women in the European Prospective Investigation into Cancer (EPIC)-Norfolk population study
PG Surtees, NWJ Wainwright, KA Pooley, RN Luben, KT Khaw, ...
Brain, behavior, and immunity 26 (3), 414-418, 2012
ข้อกำหนด: Cancer Research UK
ตรวจทาน
Decreased breast cancer risk in systemic lupus erythematosus: the search for a genetic basis continues
S Bernatsky, DF Easton, A Dunning, K Michailidou, R Ramsey-Goldman, ...
Lupus 21 (8), 896-899, 2012
ข้อกำหนด: Cancer Research UK
ตรวจทาน
Common germline variation in mismatch repair genes and survival after a diagnosis of colorectal cancer
T Koessler, EM Azzato, B Perkins, RJ Macinnis, D Greenberg, DF Easton, ...
International journal of cancer 124 (8), 1887-1891, 2009
ข้อกำหนด: US National Institutes of Health, Cancer Research UK
ตรวจทาน
Rare germline copy number deletions of likely functional importance are implicated in endometrial cancer predisposition
GL Moir-Meyer, JF Pearson, F Lose, ...
Human genetics 134, 269-278, 2015
ข้อกำหนด: National Health and Medical Research Council, Australia, Cancer Research UK …
ตรวจทาน
No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriers
AB Spurdle, AJ Deans, D Duffy, DE Goldgar, X Chen, J Beesley, kConFaB, ...
Breast cancer research and treatment 115, 307-313, 2009
ข้อกำหนด: US National Institutes of Health, Cancer Research UK
ตรวจทาน
Screening for prostate cancer: the way ahead.
RS Kirby, RA Eeles, Z Kote-Jarai, M Guy, D Easton, JM Fitzpatrick
BJU international 105 (3), 2010
ข้อกำหนด: Cancer Research UK
ตรวจทาน
The CYP17A1 −34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers
B Kaufman, Y Laitman, E Ziv, U Hamann, D Torres, EL Lahad, R Beeri, ...
Breast cancer research and treatment 126, 521-527, 2011
ข้อกำหนด: Canadian Institutes of Health Research, Cancer Research UK
ตรวจทาน
Childhood, adolescent, and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriers
S Li, L Madanat-Harjuoja, G Leslie, DR Barnes, MK Bolla, J Dennis, ...
JNCI: Journal of the National Cancer Institute, djae306, 2024
ข้อกำหนด: National Health and Medical Research Council, Australia, Cancer Research UK …
ตรวจทาน
Authors’ response: Associations of obesity and circulating insulin and glucose with breast cancer risk
X Shu, L Wu, NK Khankari, XO Shu, TJ Wang, K Michailidou, MK Bolla, ...
International Journal of Epidemiology 48 (3), 1016-1017, 2019
ข้อกำหนด: Cancer Research UK
ตรวจทาน
InSiGHT, pedigree, familial aspects of cancer and the Human Variome Project in conjunction with the COSA familial cancer group
D Easton, J Hopper, P Risk, J Burn, G Taylor, JT den Dunnen, ...
Familial Cancer 12, S23-S110, 2013
ข้อกำหนด: Government of Spain
แหล่งที่มาและข้อมูลกองทุนดำเนินการโดยโปรแกรมคอมพิวเตอร์โดยอัตโนมัติ